Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000463802 | SCV000546144 | likely benign | Hypertrophic cardiomyopathy 14 | 2023-12-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001545949 | SCV001765380 | likely benign | not provided | 2018-07-02 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27789736) |
Ambry Genetics | RCV002362841 | SCV002624361 | likely benign | Cardiovascular phenotype | 2020-11-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002492608 | SCV002794873 | likely benign | Hypertrophic cardiomyopathy 1; Dilated cardiomyopathy 1EE; Hypertrophic cardiomyopathy 14; Atrial septal defect 3; Sick sinus syndrome 3, susceptibility to | 2021-10-09 | criteria provided, single submitter | clinical testing | |
Dept of Medical Biology, |
RCV003318358 | SCV004022077 | uncertain significance | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: PP3 |
Blueprint Genetics | RCV000157338 | SCV000207075 | likely benign | Primary familial hypertrophic cardiomyopathy | 2014-10-06 | no assertion criteria provided | clinical testing |